| Income Statement |
| Total Revenue | 7.72M |
|
| Revenues (USD) | 7.72M |
| Cost of Revenue | 2.67M |
| Gross Profit | 5.05M |
| Operating Expenses | 3.52M |
| Research and Development Expense | 729.22K |
| Selling, General and Administrative Expense | 2.79M |
| Operating Income | 1.53M |
| Income Tax Expense | 401.74K |
| Net Income | 1.39M |
| Net Income Common Stock | 1.39M |
| Net Income Common Stock (USD) | 1.39M |
| Consolidated Income | 1.39M |
| Earnings per Basic Share | 0.12 |
| Earnings per Basic Share (USD) | 0.12 |
| Earnings per Diluted Share | 0.12 |
| Earning Before Interest & Taxes (EBIT) | 1.79M |
| Earning Before Interest & Taxes (USD) | 1.79M |
| Weighted Average Shares | 11.28M |
| Weighted Average Shares Diluted | 11.30M |
| Balance Sheet |
| Cash and Equivalents | 31.71M |
| Cash and Equivalents (USD) | 31.71M |
| Trade and Non-Trade Receivables | 8.88M |
| Current Assets | 54.60M |
| Property, Plant & Equipment Net | 7.77M |
| Total Assets | 68.85M |
| Debt Current | 42.16K |
| Total Debt | 385.38K |
| Current Liabilities | 5.43M |
| Debt Non-Current | 343.22K |
| Total Liabilities | 6.12M |
| Accumulated Retained Earnings (Deficit) | 741.58K |
| Accumulated Other Comprehensive Income | -1.31M |
| Shareholders Equity | 62.73M |
| Shareholders Equity (USD) | 62.73M |
| Assets Non-Current | 14.25M |
| Total Debt (USD) | 385.38K |
| Deferred Revenue | 1.87M |
| Goodwill and Intangible Assets | 6.49M |
| Inventory | 13.49M |
| Liabilities Non-Current | 697.09K |
| Trade and Non-Trade Payables | 977.07K |
| Tax Liabilities | 317.21K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 363.07K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.09M |
| Capital Expenditure | -162.33K |
| Net Cash Flow from Investing | -180.31K |
| Net Cash Flow from Operations | 1.38M |
| Effect of Exchange Rate Changes on Cash | -112.24K |
| Share Based Compensation | 25.78K |